open access
Recommendations on cardiac safety during ibrutinib therapy
Affiliations- Department of Cardio-Oncology, Centre of Postgraduate Medical Education, Institute of Hematology and Transfusion Medicine in Warsaw, Warsaw, Poland
- Department of Oncological Diagnostics and Cardio-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland
- Department of Hematology, Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, Warsaw, Poland
- Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland
- Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
- Department of Hematology, the St. John of Dukla Oncology Centre of Lublin, Lublin, Poland
- Department of Hematology, Transplantology and Internal Diseases, CSK UCK, Medical University of Warsaw, Warsaw, Poland
- Department of Experimental Hematology, Medical University of Lodz, Łódź, Poland
open access
Abstract
Abstract
About this articleTitle
Recommendations on cardiac safety during ibrutinib therapy
Journal
Issue
Article type
Guidelines / Expert consensus
Pages
3-5
Page views
442
Article views/downloads
81
DOI
10.5603/AHP.a2023.0001
Bibliographic record
Acta Haematol Pol 2023;54(1):3-5.
Authors
Sebastian Szmit
Iwona Hus
Krzysztof Giannopoulos
Krzysztof Jamroziak
Tadeusz Robak